during the promptly evolving subject of most cancers therapeutics, being familiar with the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is crucial for creating effective solutions. One of the more promising strategies is the use of in vitro bystander outcome assays, which Engage in a pivotal job in improving therapeutic efficacy. These a